Stephen Gange is an American statistician, epidemiologist, and academic administrator of Johns Hopkins University. He is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health and has a joint appointment in the Johns Hopkins School of Medicine.
Gange has over 300 publications [>36K citations; Google Scholar h-index = 89] [1] in Nature Medicine, Nature Cardiovascular Research, New England Journal of Medicine, Proceedings of the National Academy of Sciences, Annals of Internal Medicine, Journal of Infectious Diseases, Clinical Infectious Diseases and numerous other journals. He has made substantial contributions to the fields of epidemiology and biostatistics, leaving an impact in a spectrum of basic, clinical/behavioral, population, and policy sciences. He has been a scientific leader with large national and international HIV studies, including the Multicenter AIDS Cohort Study (MACS), Women’s Interagency HIV Study (WIHS),[2] and the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).[3] Methodologically, he has made contributions to describing the patterns, predictors, effectiveness and optimal timing of therapies, modeling and evaluating the predictive value of longitudinal disease markers, and methods for evaluating and modeling competing risks.
Gange has been active in numerous advisory panels, including a member of the AIDS Clinical Studies and Epidemiology Study Section, co-chair of the Office of AIDS Research Planning Workshop for Natural History and Epidemiology, more than ten clinical trial safety monitoring boards, and as a statistician on the US DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. He served on the editorial board of JAIDS: Journal of Acquired Immune Deficiency Syndromes, AIDS Research and Therapy, and Treatment Strategies-AIDS.